The FDA: Small-Cap Catalyst Or Small-Cap Killer?
December 16, 2016 at 09:37 AM EST
This particular bureaucracy neither gives nor takes. Data do. If a drug works, the company that develops it will do well. If a drug doesn’t work, the company that develops it had better have a diversified pipeline.